These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27423909)

  • 1. CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.
    Tang B; Ren H; Liu H; Shi Y; Liu W; Dong Y; Yin Y; Miao S
    Inflamm Res; 2016 Nov; 65(11):917-924. PubMed ID: 27423909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.
    Yuan J; Ren HY; Shi YJ; Liu W
    Inflamm Res; 2015 Feb; 64(2):137-44. PubMed ID: 25556580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis.
    Moy RH; Huffman AP; Richman LP; Crisalli L; Wang XK; Hoxie JA; Mick R; Emerson SG; Zhang Y; Vonderheide RH; Porter DL; Reshef R
    Blood; 2017 Feb; 129(7):906-916. PubMed ID: 28057639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models.
    Wang M; Zhang J; Zhao H; Wan D; Jiang Z
    Int Immunopharmacol; 2020 Apr; 81():106205. PubMed ID: 32050154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.
    Reshef R; Luger SM; Hexner EO; Loren AW; Frey NV; Nasta SD; Goldstein SC; Stadtmauer EA; Smith J; Bailey S; Mick R; Heitjan DF; Emerson SG; Hoxie JA; Vonderheide RH; Porter DL
    N Engl J Med; 2012 Jul; 367(2):135-45. PubMed ID: 22784116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model.
    Miao S; Tang B; Liu H; Wang Z; Shi Y; Dong Y; Liu W; Qin C; Ren H
    Mol Immunol; 2018 Feb; 94():82-90. PubMed ID: 29288898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation.
    Jun L; Kailun Z; Aini X; Lei X; Guohua W; Sihua W; Ping Y; Tucheng S; Xionggang J; Wenwei C; Jiahong X
    J Heart Lung Transplant; 2010 Apr; 29(4):461-70. PubMed ID: 20060322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 blockade in combination with cyclosporine increased cardiac graft survival and generated alternatively activated macrophages in primates.
    Li J; Chen G; Ye P; Wang S; Zhang K; Chen W; Stepkowski SM; Li J; Zhong S; Xia J
    J Immunol; 2011 Mar; 186(6):3753-61. PubMed ID: 21307294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.
    Wysocki CA; Burkett SB; Panoskaltsis-Mortari A; Kirby SL; Luster AD; McKinnon K; Blazar BR; Serody JS
    J Immunol; 2004 Jul; 173(2):845-54. PubMed ID: 15240671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential regulation of CCR5 expression on T lymphocytes in healthy donors after mobilization with rhG-CSF and its correlation with aGVHD].
    Wang M; Ma XJ; Dong YJ; Qiu ZX; Liu W; Li Y; Wang MJ; Sun YH; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):979-84. PubMed ID: 23998597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.
    Welniak LA; Wang Z; Sun K; Kuziel W; Anver MR; Blazar BR; Murphy WJ
    Exp Hematol; 2004 Mar; 32(3):318-24. PubMed ID: 15003318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-C chemokine receptor 5 and acute graft-versus-host disease.
    Yuan J; Ren HY
    Immun Inflamm Dis; 2022 Sep; 10(9):e687. PubMed ID: 36039647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between CCR5 and acute graft-versus-host disease in murine bone marrow transplantation.
    Wang Z; Murphy WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):934-40. PubMed ID: 17096892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients.
    Haïm-Boukobza S; Balabanian K; Teicher E; Bourgeade M; Perlemuter G; Roque-Afonso AM; Duclos-Vallee JC
    J Hepatol; 2013 Sep; 59(3):613-5. PubMed ID: 23583366
    [No Abstract]   [Full Text] [Related]  

  • 15. Migration and activation of T cells during development of graft-versus-host disease in a mouse model.
    Wen HS; Wang JM; Zhou H; Gong SI; Gao L; Wu Y
    Transplant Proc; 2013 Mar; 45(2):713-8. PubMed ID: 23498811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD Models.
    Kawasaki Y; Sato K; Nakano H; Hayakawa H; Izawa J; Takayama N; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Ito R; Hayakawa M; Ohmori T; Kanda Y
    Transplantation; 2019 Sep; 103(9):1834-1843. PubMed ID: 31461746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.
    Imado T; Iwasaki T; Kuroiwa T; Sano H; Hara H
    Transplantation; 2004 Feb; 77(3):391-8. PubMed ID: 14966413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.
    Vaeth M; Bäuerlein CA; Pusch T; Findeis J; Chopra M; Mottok A; Rosenwald A; Beilhack A; Berberich-Siebelt F
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1125-30. PubMed ID: 25583478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A.
    Han SB; Lee CW; Yoon YD; Kang JS; Lee KH; Yoon WK; Kim YK; Lee K; Park SK; Kim HM
    Biochem Pharmacol; 2005 Nov; 70(10):1518-26. PubMed ID: 16198318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.